These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 1282176

  • 1. Acute hemodynamic effects of nicorandil in coronary artery disease.
    Treese N, Erbel R, Meyer J.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S52-6. PubMed ID: 1282176
    [Abstract] [Full Text] [Related]

  • 2. Nicorandil: a potassium channel opening drug for treatment of ischemic heart disease.
    Goldschmidt M, Landzberg BR, Frishman WH.
    J Clin Pharmacol; 1996 Jul; 36(7):559-72. PubMed ID: 8844437
    [Abstract] [Full Text] [Related]

  • 3. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
    Ueno A, Bergamaschi M, Gromo G, Nonaka K, Mizrahi J.
    J Cardiovasc Pharmacol; 1995 Jul; 26 Suppl 4():S13-20. PubMed ID: 8839221
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nicorandil: animal pharmacology.
    Sakai K.
    Am J Cardiol; 1989 Jun 20; 63(21):2J-10J. PubMed ID: 2525321
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nicorandil and cardiovascular performance in patients with coronary artery disease.
    Suryapranata H, MacLeod D.
    J Cardiovasc Pharmacol; 1992 Jun 20; 20 Suppl 3():S45-51. PubMed ID: 1282175
    [Abstract] [Full Text] [Related]

  • 11. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin.
    Aizawa T, Ogasawara K, Kato K.
    J Cardiovasc Pharmacol; 1987 Jun 20; 10 Suppl 8():S123-9. PubMed ID: 2447419
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: an overview.
    Taira N.
    J Cardiovasc Pharmacol; 1987 Jun 20; 10 Suppl 8():S1-9. PubMed ID: 2447414
    [Abstract] [Full Text] [Related]

  • 16. Angiographic response to a vasodilating drug, nicorandil, in patients with coronary artery disease.
    Kishida H, Hata N, Kusama Y, Iwahara S, Sasaki Y, Mori N, Yasutake M, Koumi S, Takayama M, Munakata K.
    Jpn Heart J; 1990 Mar 20; 31(2):135-43. PubMed ID: 2141366
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Double-blind comparison of the acute effects of two relevant doses of oral nicorandil on central hemodynamics, left ventricular function, and myocardial contractility.
    Baumbach A, Braun U, Döring G, Haase KK, Voelker W, Karsch KR.
    Cardiovasc Drugs Ther; 1995 Mar 20; 9 Suppl 2():213-20. PubMed ID: 7647025
    [Abstract] [Full Text] [Related]

  • 19. Effective and safe dose of intracoronary nicorandil in man.
    Miwa K, Igawa A, Yamanishi K, Fujita M, Inouc H.
    Jpn Circ J; 1995 Nov 20; 59(11):736-44. PubMed ID: 8747763
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.